T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

International Immunology

Volumn 11, Issue 12, 1999, Pages 2025-2033

  López Díaz De Cerio, Ascensión ^a   Casares, Noelia ^a   Lasarte, Juan José ^a   Sarobe, Pablo ^a   Pérez Mediavilla, Luis Alberto ^a   Ruiz, Marta ^a   Prieto, Jesús ^a   Borrás Cuesta, Francisco ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cytokines; Cytotoxic T lymphocyte induction; T cell help; T(h) determinant

Indexed keywords

CD4 ANTIGEN; CYTOKINE; MUTANT PROTEIN; MYOGLOBIN; OVALBUMIN; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HEPATITIS C VIRUS; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0343484313     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.12.2025     Document Type: Article

References (59)

1. Yap, K. L., Ada, G. L. and McKenzie, I. F. 1978. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273:238.
2. Zinkernagel, R. M. and Doherty, P. C. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51.
3. Byrne, J. A. and Oldstone, M. B. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682.
4. Taylor, P. M. and Askonas, B. A. 1986. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417.
5. + T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664.
6. Schulz, M., Zinkernagel, R. M. and Hengartner, H. 1991. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl Acad. Sci. USA 88:991.
7. Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J. and Melief, C. J. 1989. Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes. Cell 59:603.
8. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281.
9. Feltkamp, M. C., Smits, H. L., Vierboom, M. P., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. and Kast, W. M. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol. 23:2242.
10. Siliciano, R. F., Bollinger, R. C., Callahan, K. M., Hammond, S. A., Liu, A. Y., Miskovsky, E. P., Rowell, J. F. and Stanhope, P. E. 1992. Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients. AIDS Res. Hum. Retroviruses 8:1349.
11. + cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines. J. Exp. Med. 176:1531.
12. Shirai, M., Akatsuka, T., Pendleton, C. D., Houghten, R., Wychowski, C., Mihalik, K., Feinstone, S. and Berzofsky, J. A. 1992. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 66:4098.
13. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 5:849.
14. Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T. and Falo, L. D., Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
15. Kovacsovics Bankowski, M., Clark, K., Benacerraf, B. and Rock, K. L. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl Acad. Sci. USA 90:4942.
16. Speidel, K., Osen, W., Faath, S., Hilgert, I., Obst, R., Braspenning, J., Momburg, F., Hammerling, G. J. and Rammensee, H. G. 1997. Priming of cytotoxic T lymphocytes by five heat-aggregated antigens in vivo: conditions, efficiency, and relation to antibody responses. Eur. J. Immunol. 27:2391.
17. Deres, K., Schild, H., Wiesmuller, K. H., Jung, G. and Rammensee, H. G. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
18. Aichele, P., Hengartner, H., Zinkernagel, R. M. and Schulz, M. 1990. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171:1815.
19. + T cell help. J. Immunol. 147:4069.
20. Gao, X. M., Zheng, B., Liew, F. Y., Brett, S. and Tite, J. 1991. Priming of influenza virus-specific cytotoxic T lymphocytes in vivo by short synthetic peptides. J. Immunol. 147:3268.
21. Zhou, X., Berg, L., Motal, U. M. and Jondal, M. 1992 In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J. Immunol. Methods 153:193.
22. Kast, W. M., Brandt, R. M. and Melief, C. J. 1993. Strict peptide length is not required for the induction of cytotoxic T lymphocyte-mediated antiviral protection by peptide vaccination. Eur. J. Immunol. 23:1189.
23. + cytotoxic T cells in vivo by carrier-free HIV synthetic peptides. Proc. Natl Acad. Sci. USA 88:9448.
24. Lasarte, J. J., Sarobe, P., Gullon, A., Prieto, J. and Borras Cuesta, F. 1992. Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell. Immunol. 141:211.
25. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549.
26. Ahlers, J. D., Dunlop, N., Pendleton, C. D., Newman, M., Nara, P. L. and Berzofsky, J. A. 1996. Candidate HIV type 1 multi-determinant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization. AIDS Res. Hum. Retroviruses 12:259.
27. Widmann, C., Romero, P., Maryanski, J. L., Corradin, G. and Valmori, D. 1992. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J. Immunol. Methods 155:95.
28. Valmori, D., Romero, J. F., Men, Y., Maryanski, J. L., Romero, P. and Corradin, G. 1994. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 24:1458.
29. + T lymphocytes induced by peptide immunization: an ex vivo analysis. Int. Immunol. 10:1273.
30. Actor, J. K., Marshall, M. A., Eltoum, I. A., Buller, R. M., Berzofsky, J. A. and Sher, A. 1994. Increased susceptibility of mice infected with Schistosoma mansoni to recombinant vaccinia virus: association of viral persistence with egg granuloma formation. Eur. J. Immunol. 24:3050.
31. + cytotoxic T cell response and prolongs viral infection. J. Infect. Dis. 177:72.
32. Bruna-Romero, O., Lasarte, J. J., Wilkinson, G., Grace, K., Clarke, B., Borras-Cuesta, F. and Prieto, J. 1997. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology 25:470.
33. Merrifield, R. B. 1963. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149.
34. Atherton, E., Logan, J. C. and Sheppard, R. C. 1989. Peptide synthesis II. Procedures for solid phase synthesis using N-fluorenyl methoxycarbonyl aminoacids on polyamide supports. Sintesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc. Perkin Trans. 1:538.
35. Borras Cuesta, F., Golvano, J., Sarobe, P., Lasarte, J. J., Prieto, I., Szabo, A., Guillaume, J. L. and Guillet, J. G. 1991. Insights on the amino acid side-chain interactions of a synthetic T-cell determinant. Biologicals 19:187.
36. Kaiser, E., Colescott, R. L., Bossinger, C. D. and Cook, P. I. 1970. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34:595.
37. Brunner, K. T., Mauel, J., Cerottini, J, C. and Chapuis, B. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labeled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181.
38. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
39. Lai, M. Z., Ross, D. T., Guillet, J. G., Briner, T. J., Gefter, M. L. and Smith, J. A. 1987. T lymphocyte response to bacteriophage lambda repressor cl protein. Recognition of the same peptide presented by la molecules of different haplotypes. J. Immunol. 139:3973.
40. Lasarte, J. J., Sarobe, P., Prieto, J. and Borras-Cuesta, F. 1995. In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes. Res Immunol 146:35.
41. Zhou, X., Berg, L., Motal, U. M. and Jondal, M. 1992. In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. J. Immunol. Methods 153:193.
42. Krieger, J. I., Karr, R. W., Grey, H. M., Yu, W. Y., O'Sullivan, D., Batovsky, L., Zheng, Z. L., Colon, S. M., Gaeta, F. C., Sidney, J., et al. 1991. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J. Immunol. 146:2331.
43. Shirai, M., Chen, M., Arichi, T., Masaki, T., Nishioka, M., Newman, M., Nakazawa, T., Feinstone, S. M. and Berzofsky, J. A. 1996. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. J. Infect. Dis. 173:24.
44. Stuhler, G. and Schlossman, S. F. 1997. Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc. Natl Acad. Sci. USA 94:622.
45. h2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Eur. J. Immunol. 28:2003.
46. Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G. and Lee, W. M. 1998. Immune suppression by recombinant interleukin (rIL)-12 involves Interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J. Exp. Med. 188:1603.
47. Tarrant, T. K., Silver, P. B., Wahlsten, J. L., Rizzo, L. V., Chan, C. C., Wiggert, B. and Caspi, R. R. 1999. Interieukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 189:219.
48. Lasarte, J. J., Corrales, F. J., Casares, N., López-Díaz de Cerio, A., Qian, C., Xie, X., Borrás-Cuesta, F. and Prieto, J. 1999. Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a co-administered antigen: the role of nitric oxide. J. Immunol. 162:5270.
49. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. and Heath, W. R. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478.
50. + T-helper and a T-killer cell. Nature 393:474.
51. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. and Melief, C. J. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
52. Porgador, A. and Gilboa, E. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255.
53. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J., Oseroff, C., Yuan, L., Ruppert, J., et al. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
54. Ressing, M. E., Sette, A., Brandt, R. M., Ruppert, J., Wentworth, P. A., Hartman, M., Oseroff, C., Grey, H. M., Melief, C. J. and Kast, W. M. 1995. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J. Immunol. 154:5934.
55. Sarobe, P., Pendleton, C. D., Akatsuka, T., Lau, D., Engelhard, V. H., Feinstone, S. M. and Berzofsky, J. A. 1998. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions. J. Clin. Invest. 102:1239.
56. Wentworth, P. A., Sette, A., Celis, E., Sidney, J., Southwood, S., Crimi, C., Stitely, S., Keogh, E., Wong, N. C., Livingston, B., Alazard, D., Vitiello, A., Grey, H. M., Chisari, F. V., Chesnut, R. W. and Fikes, J. 1996. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int. Immunol. 8:651.
57. Partidos, C. D., Delmas, A. and Steward, M. W. 1996. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses. Mol. Immunol. 33:1223.
58. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
59. Zarozinski, C. C., Fynan, E. F., Selin, L. K., Robinson, H. L. and Welsh, R. M. 1995. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 154:4010.